JAZF1 and metabolic dysfunction-associated steatotic liver disease: In summary, the present study for the first time provides evidence that hepatic JAZF1 (gene/protein) expression is decreased in patients and mice with NAFLD, while JAZF1-Tg mice are protected against age-related and HFD-induced obesity and hepatic steatosis.